Central Florida Pulmonary Group ( Site 1005) — Orlando, Florida

Central Florida Pulmonary Group ( Site 1005) is a clinical research site located in Orlando, Florida, United States 32803.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Central Florida Pulmonary Group ( Site 1005) has participated in 1 clinical trials.

Therapeutic areas: Systemic Sclerosis With and Without Interstitial Lung Disease.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Florida Pulmonary Group ( Site 1005)?

Central Florida Pulmonary Group ( Site 1005) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Florida Pulmonary Group ( Site 1005) conducted?

Central Florida Pulmonary Group ( Site 1005) has 1 clinical trials on record. Their work covers Systemic Sclerosis With and Without Interstitial Lung Disease.

Is Central Florida Pulmonary Group ( Site 1005) accredited by Crixeo Health?

Central Florida Pulmonary Group ( Site 1005) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Florida Pulmonary Group ( Site 1005)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.